Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03429946 · ClinicalTrials.gov registry record · Phase 4
Hypoglycemia and Autonomic Nervous System Function-B
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT03429946 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 28 participants.
The verdict
NCT03429946, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study tests the hypothesis that, compared to prior normal blood sugar, prior low blood sugar impairs cardiovascular autonomic function. The proposed studies will also test the hypothesis that the effects of prior low blood sugar on cardiovascular autonomic function are blocked by administration of a mineralocorticoid receptor antagonist.
Interventions
- DRUG Placebo
- DRUG Spironolactone
- OTHER Hypoglycemic Hyperinsulinemic Clamp
- OTHER Euglycemic Hyperinsulinemic Clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-07-17 |
| Est. Completion | 2025-11-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03429946
The ClinicalTrials.gov registry entry for NCT03429946 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT03429946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03429946 about?
NCT03429946 is a clinical study titled "Hypoglycemia and Autonomic Nervous System Function-B". This study tests the hypothesis that, compared to prior normal blood sugar, prior low blood sugar impairs cardiovascular autonomic function. The proposed studies will also test the hypothesis that the effects of prior low blood sugar on cardiovascular autonomic function are blocked by administration...
What is the current status of trial NCT03429946?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2013-07-17. Estimated completion is 2025-11-25.
What interventions are being tested in trial NCT03429946?
The interventions under investigation include: Placebo (DRUG), Spironolactone (DRUG), Hypoglycemic Hyperinsulinemic Clamp (OTHER), Euglycemic Hyperinsulinemic Clamp (OTHER).
Who is sponsoring clinical trial NCT03429946?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.